Active Flora baby

Active Flora baby drops, food supplement, contain Lactobacillus rhamnosus GG ATCC 53103 (LGG) and it is intended for newborns, infants, children and adults.
It can also be used in premature babies and newborns with low birth weight.
6 drops contain 6 x 109 CFU.
Efficiency and safety of use of L. rhamnosus GG is confirmed in numerous clinical studies and recommended by the The European Society for Paediatric Gastroenterology Hepatology and Nutrition (ESPGHAN)1 and World Gastroenterological Organization (WGO)2.

LGG in the Active Flora baby in drops are in the active state and begins to show its activity immediately after ingestion.

Lactobacillus rhamnosus GG:

  • reduces the risk of symptoms of diarrhea in antibiotic therapy1
  • significantly reduces the duration of diarrhea in acute infectious diarrhoea in children3
  • improves immune response4
  • is used as prevention and therapy in Atopic eczema associated with cow’s milk allergy4

Active Flora baby

  • contains the most studied LGG strain
  • contains an olive oil, fatty acids which are most similar to fatty acids of breast milk
  • does not contain gluten
  • does not contain allergenic substances such as: proteins of cow’s milk, lactose, sucrose
  • does not contain artificial pigments, dyes and preservatives.

The recommended daily doses should not be exceeded. A dietary supplement is not a substitute or replacement for a balanced diet. Keep out of reach of small children. It is important to adhere to a balanced and varied diet and a healthy lifestyle.

http://www.activeflora.com.hr

1 Szajewska H. et al. on Behalf of the ESPGHAN Working Group for Probiotics/Prebiotics „Probiotics for the Prevention of Antibiotic-Associated Diarrhea in Children” JPGN 2016;62: 495–506.

2 Practical guidance of the WGO “Probiotics and prebiotics”© World Gastroenterology Organization, 2008.

3 Guarino, A. et al.; Society for Pediatric Gastroenterology, Hepatology, and Nutrition/European Society for Pediatric Infectious Diseases: „ Evidence-Based Guidelines for the Management of Acute Gastroenteritis in Children in Europe: Update 2014”, JPGN 2014;59: 132–152.

4 Floch MH. et al. „Recommendations for probiotics use – 2015 update“. J Clin Gastroenterol Volume 49, Supp. 1, November/December 2015:S69-73.